Extend your brand profile by curating daily news.

Nutriband Inc. (NASDAQ: NTRB) Founder Shares Vision on Smart Money Circle Podcast, Highlighting Unique Biotech Approach

By FisherVista

TL;DR

Nutriband Inc. offers a unique advantage with its revenue-generating biotech model and innovative products like the mosquito-repelling patch, setting it apart in the competitive biotech industry.

Nutriband Inc. operates a manufacturing facility producing Active Intelligence tape and develops transdermal products with AVERSA technology, focusing on long-term value and abuse-deterrent solutions.

Nutriband Inc.'s innovations, such as the mosquito-repelling patch and abuse-deterrent fentanyl patch, contribute to a safer and healthier world by addressing public health concerns.

Nutriband's team tested their mosquito-repelling patch in the Talamanca Mountain range, achieving four days without bites, showcasing the product's effectiveness in real-world conditions.

Found this article helpful?

Share it with your network and spread the knowledge!

Nutriband Inc. (NASDAQ: NTRB) Founder Shares Vision on Smart Money Circle Podcast, Highlighting Unique Biotech Approach

Nutriband Inc. (NASDAQ: NTRB), a biotech company with a unique approach to entrepreneurship, was recently spotlighted on the Smart Money Circle Show. Serguei Melnik, the founder and president of Nutriband, shared insights into the company's unconventional strategy that emphasizes long-term value over short-term gains. Unlike many early-stage biotech firms, Nutriband already generates revenue through its manufacturing facility in North Carolina, which produces the Active Intelligence tape used by major brands like Reebok.

The company's innovation extends to consumer products, such as a mosquito-repelling patch recently approved for sale in Costa Rica. Melnik's personal commitment to the company's mission was highlighted by his hands-on testing of the product in the Talamanca Mountain range, where he and his team experienced no mosquito bites over four days. This anecdote underscores Melnik's dedication to innovation and quality, principles that guide Nutriband's operations.

Nutriband's focus on transdermal pharmaceutical products, particularly its lead product incorporating AVERSA(TM) abuse-deterrent technology, positions it as a leader in preventing drug abuse and misuse. The company's approach to business, combined with its technological advancements, makes it a standout story in the biotech sector. For more details on Nutriband's initiatives and Melnik's vision, visit https://ibn.fm/vbH9z.

blockchain registration record for this content
FisherVista

FisherVista

@fishervista